APOC1 Antikörper (Internal Region)
-
- Target Alle APOC1 Antikörper anzeigen
- APOC1 (Apolipoprotein C-I (APOC1))
-
Bindungsspezifität
- Internal Region
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser APOC1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunofluorescence (IF)
- Spezifität
- APOC1 Antibody detects endogenous levels of total APOC1.
- Homologie
- Rabbit,Dog
- Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human APOC1, corresponding to a region within the internal amino acids.
- Isotyp
- IgG
- Top Product
- Discover our top product APOC1 Primärantikörper
-
-
- Applikationshinweise
- WB 1:1000-3000, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C. Stable for 12 months from date of receipt.
- Haltbarkeit
- 12 months
-
- Target
- APOC1 (Apolipoprotein C-I (APOC1))
- Andere Bezeichnung
- APOC1 (APOC1 Produkte)
- Synonyme
- Apo-CIB antikoerper, ApoC-IB antikoerper, ALPCI antikoerper, LRRG04 antikoerper, APOC1 antikoerper, apoc1 antikoerper, apolipoprotein C1 antikoerper, apolipoprotein C-I antikoerper, Apolipoprotein C-I antikoerper, APOC1 antikoerper, Apoc1 antikoerper, apoc1 antikoerper
- Hintergrund
-
Description: Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10 % of the protein of the VLDL and 2 % of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Binds free fatty acids and reduces their intracellular esterification. Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein.
Gene: APOC1
- Molekulargewicht
- 9 kDa
- Gen-ID
- 341
- UniProt
- P02654
- Pathways
- Apoptose
-